NEWS & FEATURES

Drugs in the Pipeline

FDA Accepts BLA for Trastuzumab Biosimilar

By January 11, 2017

Drugs in the Pipeline

Breakthrough Designation Granted for Lymphoma Drug

By December 20, 2016